Tang, G., Cuzick, J., Costantino, J. P., Dowsett, M., Forbes, J. F., Crager, M., . . . Wolmark, N. (2011). Risk of Recurrence and Chemotherapy Benefit for Patients With Node-Negative, Estrogen Receptor–Positive Breast Cancer: Recurrence Score Alone and Integrated With Pathologic and Clinical Factors. American Society of Clinical Oncology.

Tang, Gong, Jack Cuzick, Joseph P. Costantino, Mitch Dowsett, John F. Forbes, Michael Crager, Eleftherios P. Mamounas, Steven Shak, and Norman Wolmark. Risk of Recurrence and Chemotherapy Benefit for Patients With Node-Negative, Estrogen Receptor–Positive Breast Cancer: Recurrence Score Alone and Integrated With Pathologic and Clinical Factors. American Society of Clinical Oncology, 2011.

Tang, Gong, et al. Risk of Recurrence and Chemotherapy Benefit for Patients With Node-Negative, Estrogen Receptor–Positive Breast Cancer: Recurrence Score Alone and Integrated With Pathologic and Clinical Factors. American Society of Clinical Oncology, 2011.